The Myofascial Pain Syndrome (MPS) Treatment market was valued at USD 1.11 Billion in 2024 and is expected to reach USD 2.23 Billion by 2032, growing at a CAGR of 8.49% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.